These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
672 related articles for article (PubMed ID: 22252256)
1. Lifetime cancer risks in individuals with germline PTEN mutations. Tan MH; Mester JL; Ngeow J; Rybicki LA; Orloff MS; Eng C Clin Cancer Res; 2012 Jan; 18(2):400-7. PubMed ID: 22252256 [TBL] [Abstract][Full Text] [Related]
2. High cumulative risks of cancer in patients with PTEN hamartoma tumour syndrome. Bubien V; Bonnet F; Brouste V; Hoppe S; Barouk-Simonet E; David A; Edery P; Bottani A; Layet V; Caron O; Gilbert-Dussardier B; Delnatte C; Dugast C; Fricker JP; Bonneau D; Sevenet N; Longy M; Caux F; J Med Genet; 2013 Apr; 50(4):255-63. PubMed ID: 23335809 [TBL] [Abstract][Full Text] [Related]
3. PTEN germline mutations in patients initially tested for other hereditary cancer syndromes: would use of risk assessment tools reduce genetic testing? Mester JL; Moore RA; Eng C Oncologist; 2013; 18(10):1083-90. PubMed ID: 24037976 [TBL] [Abstract][Full Text] [Related]
4. Breast cancer risk and clinical implications for germline PTEN mutation carriers. Ngeow J; Sesock K; Eng C Breast Cancer Res Treat; 2017 Aug; 165(1):1-8. PubMed ID: 26700035 [TBL] [Abstract][Full Text] [Related]
5. Incidence and clinical characteristics of thyroid cancer in prospective series of individuals with Cowden and Cowden-like syndrome characterized by germline PTEN, SDH, or KLLN alterations. Ngeow J; Mester J; Rybicki LA; Ni Y; Milas M; Eng C J Clin Endocrinol Metab; 2011 Dec; 96(12):E2063-71. PubMed ID: 21956414 [TBL] [Abstract][Full Text] [Related]
6. Longitudinal Analysis of Cancer Risk in Children and Adults With Germline PTEN Variants. Yehia L; Plitt G; Tushar AM; Joo J; Burke CA; Campbell SC; Heiden K; Jin J; Macaron C; Michener CM; Pederson HJ; Radhakrishnan K; Shin J; Tamburro J; Patil S; Eng C JAMA Netw Open; 2023 Apr; 6(4):e239705. PubMed ID: 37093598 [TBL] [Abstract][Full Text] [Related]
7. Germline epigenetic regulation of KILLIN in Cowden and Cowden-like syndrome. Bennett KL; Mester J; Eng C JAMA; 2010 Dec; 304(24):2724-31. PubMed ID: 21177507 [TBL] [Abstract][Full Text] [Related]
8. Cancer risk and genotype-phenotype correlations in PTEN hamartoma tumor syndrome. Nieuwenhuis MH; Kets CM; Murphy-Ryan M; Yntema HG; Evans DG; Colas C; Møller P; Hes FJ; Hodgson SV; Olderode-Berends MJ; Aretz S; Heinimann K; Gómez García EB; Douglas F; Spigelman A; Timshel S; Lindor NM; Vasen HF Fam Cancer; 2014 Mar; 13(1):57-63. PubMed ID: 23934601 [TBL] [Abstract][Full Text] [Related]
9. Frequent gastrointestinal polyps and colorectal adenocarcinomas in a prospective series of PTEN mutation carriers. Heald B; Mester J; Rybicki L; Orloff MS; Burke CA; Eng C Gastroenterology; 2010 Dec; 139(6):1927-33. PubMed ID: 20600018 [TBL] [Abstract][Full Text] [Related]
11. Cancer risks by sex and variant type in PTEN hamartoma tumor syndrome. Hendricks LAJ; Hoogerbrugge N; Mensenkamp AR; Brunet J; Lleuger-Pujol R; Høberg-Vetti H; Tveit Haavind M; Innella G; Turchetti D; Aretz S; Spier I; Tischkowitz M; Jahn A; Links TP; Olderode-Berends MJW; Blatnik A; Leter EM; Evans DG; Woodward ER; Steinke-Lange V; Anastasiadou VC; Colas C; Villy MC; Benusiglio PR; Gerasimenko A; Barili V; Branchaud M; Houdayer C; Tesi B; Yazicioglu MO; van der Post RS; Schuurs-Hoeijmakers JHM; ; Vos JR J Natl Cancer Inst; 2023 Jan; 115(1):93-103. PubMed ID: 36171661 [TBL] [Abstract][Full Text] [Related]
12. Germline alterations in RASAL1 in Cowden syndrome patients presenting with follicular thyroid cancer and in individuals with apparently sporadic epithelial thyroid cancer. Ngeow J; Ni Y; Tohme R; Song Chen F; Bebek G; Eng C J Clin Endocrinol Metab; 2014 Jul; 99(7):E1316-21. PubMed ID: 24712574 [TBL] [Abstract][Full Text] [Related]
13. Second malignant neoplasms in patients with Cowden syndrome with underlying germline PTEN mutations. Ngeow J; Stanuch K; Mester JL; Barnholtz-Sloan JS; Eng C J Clin Oncol; 2014 Jun; 32(17):1818-24. PubMed ID: 24778394 [TBL] [Abstract][Full Text] [Related]
14. WWP1 Gain-of-Function Inactivation of PTEN in Cancer Predisposition. Lee YR; Yehia L; Kishikawa T; Ni Y; Leach B; Zhang J; Panch N; Liu J; Wei W; Eng C; Pandolfi PP N Engl J Med; 2020 May; 382(22):2103-2116. PubMed ID: 32459922 [TBL] [Abstract][Full Text] [Related]
15. Germline mutations and variants in the succinate dehydrogenase genes in Cowden and Cowden-like syndromes. Ni Y; Zbuk KM; Sadler T; Patocs A; Lobo G; Edelman E; Platzer P; Orloff MS; Waite KA; Eng C Am J Hum Genet; 2008 Aug; 83(2):261-8. PubMed ID: 18678321 [TBL] [Abstract][Full Text] [Related]
16. Clinical Implications for Germline PTEN Spectrum Disorders. Ngeow J; Sesock K; Eng C Endocrinol Metab Clin North Am; 2017 Jun; 46(2):503-517. PubMed ID: 28476234 [TBL] [Abstract][Full Text] [Related]
17. Germline mutations in the PTEN gene in Israeli patients with Bannayan-Riley-Ruvalcaba syndrome and women with familial breast cancer. Figer A; Kaplan A; Frydman M; Lev D; Paswell J; Papa MZ; Goldman B; Friedman E Clin Genet; 2002 Oct; 62(4):298-302. PubMed ID: 12372056 [TBL] [Abstract][Full Text] [Related]
18. KLLN epigenotype-phenotype associations in Cowden syndrome. Nizialek EA; Mester JL; Dhiman VK; Smiraglia DJ; Eng C Eur J Hum Genet; 2015 Nov; 23(11):1538-43. PubMed ID: 25669429 [TBL] [Abstract][Full Text] [Related]
19. PTEN Hamartoma Tumor Syndrome: A Case of Renal Cell Carcinoma in a Young Female. Ramkumar RR; Murthy PB; Nguyen JK; McKenney J; Eng C; Campbell SC Urology; 2021 Feb; 148():113-117. PubMed ID: 33227300 [TBL] [Abstract][Full Text] [Related]